Fotemustine, Etoposide, Cytarabine, and Cyclophosphamide Conditioning Regimen for ASCT in Patients With Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
Leukemia and Lymphoma 2023 Jan 19;[EPub Ahead of Print], M Lin, X Wu, L Zhang, L Li, X Wang, X Fu, Z Sun, X Zhang, L Zhu, H Yu, Y Chang, F Nan, J Yan, Z Zhou, C Shi, M Zhang, X LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.